Our Approach

The environment for developers of innovative medicines is constantly changing. That's why we have developed an integrated platform to solve all challenges in clinical research, market access, reimbursement and pricing.

Based on data and analysis, our out-of-the-box expertise lays the foundation for comprehensive support. We offer a unique service from clinical research to real world evidence, strategic consulting and dialogue support with payers and regulators.

This allows us to support the complete launch and commercialization of drug innovations and address specific program or patient requirements.

From clinical strategy to commercial performance

IGES Pharma offers flexible, tailored, integrated clinical and commercial solutions that support innovative pharmaceutical and biotech companies in their efforts to deliver treatments to patients - from defining their asset plan, through study design and execution, to HTA assessment, launch and commercialization.

This enables inventors of new medicines to communicate convincing results, that they trust, to investors, advocacy groups and reimbursement authorities.


Our 65-page guide “Reimbursement and Pricing of Pharmaceuticals in Europe” provides an overview of European pharmaceutical markets and explains the current regulatory, pricing and reimbursement systems of the five largest European countries: Germany, France, Italy, the United Kingdom and Spain.

If you would like a copy of the guide, please email Ms. Agata Daroszewska.